A Chimeric Antibody against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models-Reference-Cited by-同舟云学术

A Chimeric Antibody against ACKR3/CXCR7 in Combination with TMZ Activates Immune Responses and Extends Survival in Mouse GBM Models

Published:2018-05 Issue:5 Volume:26 Page:1354-1365
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Salazar Nicole,Carlson Jeffrey C.,Huang Kexin,Zheng Yayue,Oderup Cecilia,Gross Julia,Jang Andrew D.,Burke Thomas M.,Lewén Susanna,Scholz Alexander,Huang Serina,Nease Leona,Kosek Jon,Mittelbronn Michel,Butcher Eugene C.,Tu Hua,Zabel Brian A.

Funder

NIH

Emerson Collective Cancer Research Fund

Luxembourg National Research Fund

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference46 articles.

1. Hypoxia in astrocytic tumors and implications for therapy;Cavazos;Neurobiol. Dis.,2016

2. Vascular gene expression patterns are conserved in primary and metastatic brain tumors;Liu;J. Neurooncol.,2010

3. The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects;Hattermann;Cancer Res.,2010

4. Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats;Walters;Br. J. Cancer,2014

5. The chemokine receptor CXCR7 influences prognosis in human glioma in an IDH1-dependent manner;Birner;J. Clin. Pathol.,2015

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational design of siRNA-based delivery systems for effective treatment of brain diseases;Pharmaceutical Science Advances;2024-12

2. Enhanced treatment of breast cancer brain metastases with oncolytic virus expressing anti-CD47 antibody and temozolomide;Molecular Therapy: Oncology;2024-09

3. Atypical chemokine receptor 3 regulates synaptic removal in disease astrocytes;2024-07-05

4. Multi-omics characterization of esophageal squamous cell carcinoma identifies molecular subtypes and therapeutic targets;JCI Insight;2024-04-23

5. Glioblastoma stem cell metabolism and immunity;Cancer and Metastasis Reviews;2024-03-26